5463-09-2

Basic information

• Product Name: N~2~-butyl-5H-purine-2,6-diamine
• CAS NO: 5463-09-2
• Molecular Formula: C₉H₁₄N₆
• Molecular Weight: 206.2477
• Mol File: 5463-09-2.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 345.5°C at 760 mmHg
• Flash Point: 162.7°C
• Density: 1.47g/cm³
• Vapor Pressure: 6.15E-05mmHg at 25°C
• Refractive Index: 1.731
• CAS DataBase Reference: N~2~-butyl-5H-purine-2,6-diamine(CAS DataBase Reference)
• NIST Chemistry Reference: N~2~-butyl-5H-purine-2,6-diamine(5463-09-2)
• EPA Substance Registry System: N~2~-butyl-5H-purine-2,6-diamine(5463-09-2)

Safety Data

• Hazardous Substances Data: 5463-09-2(Hazardous Substances Data)

Upstream product

• 109-73-9 N-butylamine 
• 1839-18-5 6-Amino-2-chlorpurin 
• 1839-18-5 2-chloroadenine 
• 1839-18-5 2-chloro-1H-purin-6-amine 

Downstream Products

• 1026870-19-8 N²-butyl-9-pyridin-2-ylmethyl-9H-purine-2,6-diamine 
• 1623012-91-8 (S)-20-(benzyloxycarbonylamino)-9,14-bis(tert-butoxycarbonyl)-2,2-dimethyl-4,19-dioxo-3-oxa-5,9,14,18-tetraazahenicosan-21-yl-4-((6-amino-2-(butylamino)-8-hydroxy-9H-purin-9-yl)methyl)benzoate 
• 1548551-79-6 4-((6-amino-2-(butylamino)-8-hydroxy-9H-purin-9-yl)methyl)-N-(2-(3-(4-(3-amino propyl amino)butylamino)propylamino)-2-oxoethyl)benzamide 
• 1623012-85-0 N₅,N₁₀-diBoc-N₁₄-[4-((6-amino-2-(butylamino)-8-hydroxy-9H-purin-9-yl)methyl)-N-(2-amino-2-oxoethyl)benzamido]spermine 
• 1623012-84-9 N₁-benzylcarbamate-N₅,N₁₀-diBoc-N₁₄-[4-((6-amino-2-(butylamino)-8-hydroxy-9H-purin-9-yl)methyl)-N-(2-amino-2-oxoethyl)benzamido]spermine 
• 1623012-83-8 N₁,N₅,N₁₀-triBoc-N₁₄-[4-((6-amino-2-(butylamino)-8-hydroxy-9H-purin-9-yl)methyl)-N-(2-amino-2-oxoethyl)benzamido]spermine 
• 1510713-50-4 (S)-methyl 2-(4-((6-amino-2-(butylamino)-8-hydroxy-9H-purin-9-yl)methyl) benzamido)-6-(benzyloxycarbonylamino)hexanoate 
• 1623012-92-9 (S)-20-amino-9,14-bis(tert-butoxycarbonyl)-2,2-dimethyl-4,19-dioxo-3-oxa-5,9,14,18-tetraazahenicosan-21-yl-4-((6-amino-2-(butylamino)-8-hydroxy-9H-purin-9-yl)methyl)benzoate 

Relevant articles and documents

Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists

The present invention relates to a conjugated compound of Formula I : Q-Z-R4 wherein Q is a TLR7 and/or TLR8 agonist and Z-R4 is a TLR2 agonist, said conjugated compound being chosen among compounds of Formula II :

CONJUGATED TLR7 AND/OR TLR8 AND TLR2 AGONISTS

A conjugated compound of formula Q-Z—R4 wherein Q is a TLR7 and/or TLR8 agonist and Z—R4 is a TLR2 agonist, and the uses thereof in the treatment of infection, cancer or immune disorders or for use in vaccines.

Modulators of toll-like receptor 7

The present application provides for a compound of Formula I or II: or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and th